Omapro would be the first treatment for chronic myeloid leukemia patients with the T315I genetic mutation that makes them resistant to existing treatments ...
... that several distinct mutations found in a subset of patients with acute myelogenous leukemia (AML) result in excess production of the same metabolite. ...
... as of four months ago, 41 year old Austin faces the harsh reality that a diagnosis of Acute Myeloid Leukemia (AML) requires a bone marrow transplant. ...
Email this story